Sat, Sep 20, 2014, 6:09 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • redistributewealth redistributewealth Apr 29, 2006 10:49 PM Flag

    We take it to 9 today and 15+ by 1 wk

    STILL waiting on 9.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The only way we lose money is if we take substantially less than one percent of the market in RX PPI capsule sales (and none of the following happen).

      We make money with any of the following scenarios:
      1. Take 1% or more of the RX PPI capsule market.
      2. Get bought out by big pharma who needs to enter this $13 Billion market space with the best and only immediate release product on the market. Already FDA approved with multiple formulations (capsule, soluble powder, and chewable tablet)
      3. Partner with a billion dollar firm for US OTC sales of Zegerid. The over the counter potential to me is worth more than the current market cap of SNTS, and it's fully protected by patents for 10 years.
      4. Partner with big pharma for ex-US RX or OTC sales.
      5. Acquire a development stage drug, obtain FDA approval, and leverage our sales force to sell additional product.

 
SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.